4:38am PST - January 12th, 2021

BioNTech BNTX aggressive vaccine manufacturing plans are helping its stock. The company plans to make 2 billion doses and the stock is up 30% just in 2021. Moderna MRNA is also rising thanks to its finding that covid vaccine will provide protection for 2 years https://t.co/jmjTDl2gh0

2 retweets   0 likes  - Deepak Singh (@smarket)